About the Cancer Geneticists Session
Cancer Geneticists study the genetic mutations and alterations that contribute to the development, progression, and spread of cancer. By analyzing DNA sequences and genetic variations, they work to identify specific mutations that may predispose individuals to certain cancers or drive the growth of tumors. Their research is essential for understanding how inherited genetic factors, as well as acquired mutations during a person’s lifetime, influence cancer risk. Through this understanding, cancer geneticists contribute to the development of genetic screening tools, allowing for early detection of cancers and better prevention strategies, particularly for individuals with a family history of cancer.
Identifying genetic risk factors, cancer geneticists also play a pivotal role in the development of personalized medicine. By examining the genetic makeup of both the patient and their cancer, they can help tailor treatment plans to target the specific mutations driving the disease. This approach helps optimize treatment effectiveness and minimize side effects. Cancer geneticists also collaborate closely with molecular oncologists to discover new therapies aimed at targeting genetic abnormalities in cancer cells. Their work is advancing precision medicine, making it possible to not only treat cancer more effectively but to understand the genetic blueprint of each cancer, ultimately leading to more personalized, effective, and sustainable treatments. Through ongoing research, cancer geneticists continue to provide critical insights that will shape the future of cancer prevention and treatment.
Topics Covered in Cancer Geneticists
Germline Variants
Somatic Mutations
Hereditary Cancer Syndromes
Genetic Counseling
Cascade Testing
Polygenic Risk Scores
Related Scientific Sessions at CIOC 2027
Why Attend the Cancer Geneticists Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer Geneticists work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer Geneticists research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cancer Geneticists track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer Geneticists Conference 2027 — FAQs
What is the Cancer Geneticists track at CIOC 2027?
The Cancer Geneticists track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer Geneticists. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer Geneticists sessions?
Cancer researchers and clinicians, educators and students with an interest in Cancer Geneticists are all welcome — whether presenting or attending.
Can I present my research in the Cancer Geneticists track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer Geneticists sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cancer Geneticists track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.